Ah. Beressi et al., OUTCOME ANALYSIS OF 34 PREGNANCIES IN WOMEN WITH ESSENTIAL THROMBOCYTHEMIA, Archives of internal medicine, 155(11), 1995, pp. 1217-1222
Objective: To evaluate the clinical impact of essential thrombocythemi
a on the outcome of pregnancy or vice versa. Design: A retrospective s
tudy. Setting: All patients were seen at our tertiary referral center,
and most were followed up by their local physicians. Patients: From 1
975 through 1991, 73 women younger than 50 years with essential thromb
ocythemia were seen at our institution. All patients were followed up
through patient or physician contact. A detailed obstetric history, in
cluding peripartum complications and management, was obtained. Results
: Among the 73 women, 34 pregnancies occurred in 18 patients. There we
re two uncomplicated elective abortions and one ectopic pregnancy. Of
the 31 other pregnancies, 17 (55%) resulted in live birth and 14 (45%)
ended in spontaneous abortion (all but two in the first trimester). A
bortion could not be predicted from history of disease complications b
efore or during pregnancy or by the presence or absence of specific th
erapy during pregnancy. Preconception platelet counts in women whose p
regnancies resulted in live birth were similar to those of women whose
pregnancies ended in abortion. Other complications during pregnancy w
ere rare. Conclusions: Patients with essential thrombocythemia have an
increased risk of first-trimester abortion, which does not appear to
be predictable or influenced by therapy. However, most patients are ab
le to carry pregnancies to term with little or no risk of obstetric or
thrombohemorrhagic complications during or after delivery. Overall, s
pecific therapy during pregnancy did not appear to modify the clinical
outcome, and the benefit of platelet apheresis during delivery could
not be substantiated.